ArticleEMBO molecular medicine2018

Inhibition of DDR1-BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer.

Maya Jeitany et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.